Argus Investors Counsel’s HCA Healthcare HCA Stock Holding History

Argus Investors Counsel’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,300	Closed	-$554K	–	108
2025 Q3	$554K	Sell	1,300 -20	-2%	-$7.75K	0.44%	57
2025 Q2	$506K	Sell	1,320 -93	-7%	-$33.5K	0.36%	85
2025 Q1	$488K	Sell	1,413 -38	-3%	-$12.2K	0.37%	84
2024 Q4	$436K	Sell	1,451 -68	-4%	-$23.8K	0.29%	95
2024 Q3	$617K	Sell	1,519 -109	-7%	-$39.9K	0.4%	73
2024 Q2	$523K	Sell	1,628 -82	-5%	-$26.6K	0.32%	82
2024 Q1	$570K	Sell	1,710 -18	-1%	-$5.5K	0.35%	79
2023 Q4	$468K	Sell	1,728 -5	-0.3%	-$1.24K	0.3%	82
2023 Q3	$426K	Sell	1,733 -34	-2%	-$9.3K	0.31%	82
2023 Q2	$536K	Sell	1,767 -9	-0.5%	-$2.5K	0.37%	74
2023 Q1	$468K	Sell	1,776 -6	-0.3%	-$1.52K	0.35%	79
2022 Q4	$428K	Buy	+1,782	New	+$399K	0.34%	77

Other funds holding HCA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Argus Investors Counsel's HCA Position: Q4 2025 in Review

Argus Investors Counsel sold out of HCA Healthcare (HCA) in Q4 2025, closing a stake of 1,300 shares — an estimated $554K sold.

Argus Investors Counsel first reported a position in HCA in Q4 2022 and held it in 12 quarters. The position peaked at $617K in Q3 2024. 1,396 funds tracked by Wall St. Rank hold HCA as of Q4 2025.

Argus Investors Counsel reported no remaining HCA Healthcare position as of Q4 2025 after selling out during the quarter.
Argus Investors Counsel sold 1,300 HCA Healthcare shares in Q4 2025, an estimated $554K.
Argus Investors Counsel first reported a position in HCA Healthcare in Q4 2022 and held it in 12 quarters.
Argus Investors Counsel's HCA Healthcare position peaked at $617K in Q3 2024.
1,396 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2025.

Based on Argus Investors Counsel's 13F filing for Q4 2025, filed 22 Jan 2026.